Table 1.
Study | NHMRC Evidence Hierarchy | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Safarinejad 2011 [20] | Level II | Randomised controlled trial | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 16/16 (100%) |
Safarinejad 2010 [21] | Level II | Randomised controlled trial | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 16/16 (100%) |
Segraves 2004 [17] | Level II | Randomised controlled trial | Yes | Yes | Yes | Yes | Yes | Na | Yes | Yes | Na | Na | Na | Yes | Na | Yes | Yes | Yes | 11/11 (100%) |
Thase 2006 [22] | Level II | Randomised controlled trial | Yes | Yes | Yes | Yes | Yes | Na | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 15/15 (100%) |
Clayton 2004 [23] | Level II | Randomised controlled trial | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | 15/16 (94%) |
Kennedy 2006 [24] | Level II | Randomised controlled trial | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 15/16 (94%) |
Hartmann 2012 [25] | Level III-3 | Interrupted time series without a parallel control group | Yes | Yes | Yes | Yes | NA | NA | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 14/14 (100%) |
DeFronzoDobkin 2006 [26] | Level III-3 | Interrupted time series without a parallel control group | Yes | Yes | Yes | Yes | No | NA | Yes | Yes | Yes | NA | Yes | Yes | Yes | Yes | Yes | Yes | 13/14 (93%) |
Segraves 2001 [27] | Level III-3 | Interrupted time series without a parallel control group | Yes | Yes | Yes | Yes | No | NA | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Na | Yes | 13/15 (87%) |
Mathias 2006 [28] | Level III-3 | Interrupted time series without a parallel control group | Yes | Yes | Yes | No | NA | NA | Yes | Yes | No | No | No | Yes | Yes | Yes | No | Yes | 9/14 (64%) |
Gitlin 2002 [29] | Level IV | Case series with either post-test or pre-test/post-test outcomes | Yes | Yes | Yes | Yes | No | NA | Yes | Yes | Yes | NA | No | Yes | Yes | Yes | No | Yes | 11/14 (79%) |